Updated Jul 16, 2026
Kelley Susan L. has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Susan L. Kelley is a director at Dare Bioscience, Inc., a biopharmaceutical company focused on women's health. She has participated in SEC filings related to her role but does not appear to have made any significant financial transactions with the company.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | DARE | Dare Bioscience, Inc. | A — Grant or award | 23.7K | $0.00 |
Susan L. Kelley is a director at Dare Bioscience, Inc., a biopharmaceutical company focused on women's health. She has participated in SEC filings related to her role but does not appear to have made any significant financial transactions with the company.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kelley Susan L. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.